Research Article
Medication Compliance In Type 2 Diabetes Mellitus Patients
@INPROCEEDINGS{10.4108/eai.29-3-2020.2315342, author={Sulistyo Andarmoyo and Harmy bin Mohamed Yusoff and Berhanundin bin Abdullah and Yuzana bint Mohd Yusop}, title={Medication Compliance In Type 2 Diabetes Mellitus Patients }, proceedings={Proceedings of the U-Go Healthy International Conference, U-Go Healthy 2020, 29 March 2020, Pacitan, East Java, Indonesia}, publisher={EAI}, proceedings_a={U-GO HEALTHY}, year={2022}, month={9}, keywords={medication compliance type 2 diabetes mellitus}, doi={10.4108/eai.29-3-2020.2315342} }
- Sulistyo Andarmoyo
Harmy bin Mohamed Yusoff
Berhanundin bin Abdullah
Yuzana bint Mohd Yusop
Year: 2022
Medication Compliance In Type 2 Diabetes Mellitus Patients
U-GO HEALTHY
EAI
DOI: 10.4108/eai.29-3-2020.2315342
Abstract
Type 2 diabetes mellitus is an incurable but manageable disease. The ability to control blood sugar levels in these patients requires collaboration between health care providers, especially doctors who prescribe drugs, and patients as someone whose health outcome will be affected. The results of cooperation between the two parties are shown by the patient's compliance in taking daily medication. The purpose of this paper is to gain a theoretical understanding of the concept of adherence in medication (taking daily medication in type 2 Diabetes Mellitus patients). Compliance in taking daily medication is the behavior to follow the suggestions or procedures from doctors about the use of drugs, which was preceded by the consultation process between patients and doctors as health service providers. Some aspects used to measure compliance in taking daily medications are frequency, number of pills/other drugs, continuity, metabolism in the body, biological aspects in the blood, and physiological changes in the body. While the determinants of the emergence of adherence in taking daily drugs include: patient perceptions and behavior, interactions between patients and doctors and medical communication between the two parties, policies and practices of treatment in the public made by the authorities and various interventions carried out so that compliance in consuming drugs occurs. The results of this paper are expected to be an understanding for those who are dealing with type 2 Diabe